Novel immunotherapy delivery approach benefits some melanoma patients with leptomeningeal disease Dr. Kamal Kant Kohli10 April 2023 2:00 AM ISTA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was safe and...
Health Bulletin 8/April/2023 Roshni Dhar8 April 2023 5:00 PM ISTHere are the top health stories for the day:India asks states to ramp up testing as COVID-19 cases climb“Centre and States need to continue working in...
Medical Bulletin 8/April/2023 Isra Zaman8 April 2023 4:45 PM ISTHere are the top medical news for the day:Study finds spread of COVID-19 in households to be linked to virus on hands and surfacesA new Imperial...
New immunotherapy agent safe and promising against high-risk prostate cancers Isra Zaman8 April 2023 9:15 AM ISTEnoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to...
SGLT2 inhibitors use lowers cancer risk in patients with diabetes Medha Baranwal7 April 2023 11:30 AM ISTTaiwan: Patients with diabetes who receive sodium-glucose cotransporter-2 (SGLT2) inhibitors are at a significantly lower risk of cancer, a new study...
Johnson & Johnson proposes USD 8.9 billion settlement for talc cancer claims Roshni Dhar6 April 2023 3:53 PM ISTUS pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum...
Health Bulletin 5/April/2023 Roshni Dhar5 April 2023 5:34 PM ISTHere are the top health stories for the day:People need to remain vigilant against new COVID strain: OfficialRajasthan doctors call off strike on RTH...
JnJ proposes USD 8.9 billion settlement of talc cancer claims Ruchika Sharma5 April 2023 4:21 PM ISTThe company said the newly proposed settlement is not "an admission of wrongdoing, nor an indication that the company has changed its longstanding...
Medical Bulletin 5/April/2023 Isra Zaman5 April 2023 3:00 PM ISTHere are the top medical news for the day:Narrow opportunity to address a rare disease linked to autism, schizophrenia identifiedIn DiGeorge syndrome,...
Lorlatinib is safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma, research shows Isra Zaman5 April 2023 9:30 AM ISTNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells, often appearing as a solid tumor in the chest or abdomen. The...
Medical Bulletin 4/April/2023 Isra Zaman4 April 2023 4:13 PM ISTHere are the top medical news for the day:Same time headaches linked to circadian system: StudyStrong links between both cluster headache and migraine...
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients Dr. Kamal Kant Kohli4 April 2023 10:00 AM ISTUSA: Immunotherapy after surgery increases the chance of staying cancer-free in bladder cancer patients compared to those who received a placebo,...
